Eloxx Pharmaceuticals, Inc.

· Biological Products, (No Diagnostic Substances)

Price History

Revenue

▼ 100.0% YoY

Net Income

-$6.0M

▼ 90.7% YoY

EPS

$-0.49

▲ 41.7% YoY

Cash

$4.8M

▲ 4210.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.